Teva Pharmaceutical Extends Revolving Credit Agreement Maturity Date

Summary

Teva Pharmaceutical Industries Limited has extended the maturity date of its Revolving Facility Agreement from April 29, 2027, to April 29, 2028, and amended certain financial covenants. This extension is the second under the agreement's terms, subject to the satisfaction of specific conditions.